1547160-93-9

Basic information

• Product Name: C₁₉H₁₅ClN₄O₃
• Synonyms: C₁₉H₁₅ClN₄O₃
• CAS NO: 1547160-93-9
• Molecular Weight: 382.806
• Mol File: 1547160-93-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₁₉H₁₅ClN₄O₃(CAS DataBase Reference)
• NIST Chemistry Reference: C₁₉H₁₅ClN₄O₃(1547160-93-9)
• EPA Substance Registry System: C₁₉H₁₅ClN₄O₃(1547160-93-9)

Safety Data

• Hazardous Substances Data: 1547160-93-9(Hazardous Substances Data)

Upstream product

• 1547160-90-6 C₁₁H₉Cl₂N₃O₃ 
• 54060-30-9 3-acetylenephenylamine 
• 162012-69-3 7-fluoro-6-nitro-3H-quinazolin-4-one 

Downstream Products

• 1547160-67-7 C₂₈H₃₀N₆O₂ 
• 1547160-68-8 C₂₉H₃₁N₅O₂ 
• 1547160-71-3 C₂₉H₃₁N₅O₂ 
• 1547160-74-6 C₂₈H₂₉N₅O₂ 
• 1547160-75-7 C₂₇H₂₇N₅O₂ 
• 1547160-78-0 C₂₇H₂₉N₅O₂ 
• 1547160-80-4 C₂₅H₂₅N₅O₂ 
• 1547160-99-5 C₁₉H₁₇ClN₄O 
• 1547161-03-4 C₁₉H₁₆N₄O 
• 1547161-08-9 C₂₃H₁₉BrN₄O₂ 
• 1547160-66-6 C₂₇H₂₇N₅O₃ 

Relevant articles and documents

Synthesis and biological evaluation of novel tricyclic oxazine and oxazepine fused quinazolines. Part 1: Erlotinib analogs

Two series of novel tricyclic oxazine and oxazepine fused quinazolines have been designed and synthesized. The in vitro antitumor effect of the title compounds was screened on N87, A431, H1975, BT474 and Calu-3 cell lines. Compared to erlotinib and gefiti